Editorial: Insights, controversies, and new developments in the initial treatment decisions for advanced epithelial ovarian cancer
Saved in:
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-03-01
|
| Series: | Frontiers in Oncology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2025.1568579/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850180912191373312 |
|---|---|
| author | Jianfeng Guo Jianfeng Guo |
| author_facet | Jianfeng Guo Jianfeng Guo |
| author_sort | Jianfeng Guo |
| collection | DOAJ |
| format | Article |
| id | doaj-art-bcd706ee6b034cb0a229fc3f444bd2d3 |
| institution | OA Journals |
| issn | 2234-943X |
| language | English |
| publishDate | 2025-03-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Oncology |
| spelling | doaj-art-bcd706ee6b034cb0a229fc3f444bd2d32025-08-20T02:18:00ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2025-03-011510.3389/fonc.2025.15685791568579Editorial: Insights, controversies, and new developments in the initial treatment decisions for advanced epithelial ovarian cancerJianfeng Guo0Jianfeng Guo1Department of Obstetrics and Gynecology, People’s Hospital of Longhua, Shenzhen, ChinaLonghua District Key Laboratory of Perinatal Population Medicine, Shenzhen, Chinahttps://www.frontiersin.org/articles/10.3389/fonc.2025.1568579/fullepithelial ovarian cancer (EOC)initial treatment decisionsmachine learning in oncologyhomologous recombination deficiency (HRD)patient-derived organoids (PDOs)platinum resistance |
| spellingShingle | Jianfeng Guo Jianfeng Guo Editorial: Insights, controversies, and new developments in the initial treatment decisions for advanced epithelial ovarian cancer Frontiers in Oncology epithelial ovarian cancer (EOC) initial treatment decisions machine learning in oncology homologous recombination deficiency (HRD) patient-derived organoids (PDOs) platinum resistance |
| title | Editorial: Insights, controversies, and new developments in the initial treatment decisions for advanced epithelial ovarian cancer |
| title_full | Editorial: Insights, controversies, and new developments in the initial treatment decisions for advanced epithelial ovarian cancer |
| title_fullStr | Editorial: Insights, controversies, and new developments in the initial treatment decisions for advanced epithelial ovarian cancer |
| title_full_unstemmed | Editorial: Insights, controversies, and new developments in the initial treatment decisions for advanced epithelial ovarian cancer |
| title_short | Editorial: Insights, controversies, and new developments in the initial treatment decisions for advanced epithelial ovarian cancer |
| title_sort | editorial insights controversies and new developments in the initial treatment decisions for advanced epithelial ovarian cancer |
| topic | epithelial ovarian cancer (EOC) initial treatment decisions machine learning in oncology homologous recombination deficiency (HRD) patient-derived organoids (PDOs) platinum resistance |
| url | https://www.frontiersin.org/articles/10.3389/fonc.2025.1568579/full |
| work_keys_str_mv | AT jianfengguo editorialinsightscontroversiesandnewdevelopmentsintheinitialtreatmentdecisionsforadvancedepithelialovariancancer AT jianfengguo editorialinsightscontroversiesandnewdevelopmentsintheinitialtreatmentdecisionsforadvancedepithelialovariancancer |